Terminologies

Cards (50)

  • are considered THERAPEUTIC DRUGS because of their use in treating diseases.
    Blood / Blood products
  • The transfusion of blood cells is also transplantation, in that the cells must survive and function after transfusion to a
    Therapeutic effect
  • is a bank of blood and their components, gathered as a result of blood donation, where it is stored with preservative for later use in transfusion.
    Blood bank
  • Goal of blood preservation
    provide a viable and functional blood components for patients requiring blood transfusion
  • at least what percent of cells that have been transfused should remain viable for 24 hours
    70%
  • To maintain optimum viability, blood is stored in _ state between _-_°C for a specific number of days
    liquid, 1-6
  • ACD stands for, shelf life:
    Acid citrate dextrose, 21 days
  • CPD stands for, shelf life:
    Citrate phosphate dextrose, 21 days
  • CP2D stands for, shelf life:
    Citrate phosphate double dextrose, 21 days
  • CPDA-1 stands for, shelf life:
    Citrate phosphate adenine-1, 35 days
  • CPDA-2 stands for, shelf life:
    Citrate phosphate adenine-2, 42 days
  • Shelf life of heparin
    2 days
  • Anticoagulant: calcium removing agent, primary anticoagulant, massive transfusion might lead to hypocalcemia
    citrate
  • Anticoagulant: provide energy for the cell
    dextrose
  • Anticoagulant: prevent caramelization
    citric acid
  • Anticoagulant: increase the levels of ATP
    phosphate buffer
  • Anticoagulant: improves the survival or red cells
    adenine
  • Sample are collected in what tubes
    red (serum)
    lavender (EDTA)
    pink (plasma)
  • Why SST tubes containing gel are not acceptable
    the gel will coat the rbc and interfere with testing
  • Does hemolysis also interferes with the interpretation of the results
    Yes
  • _ can result in a sentinel event
    Misidentification or mislabeling
  • is critical step in blood bank
    patient identification
  • maximum collection of no more than _ of whole blood per kilogram of body weight including sample
    10.5ml
  • donor interval
    8 weeks after whole blood donation
  • Criteria for donor collection:
    Age
    Temperature
    Weight
    HCT
    HGB
    16 years +
    <37.5°C / 99.5°F
    110 pounds / 50 kg
    >38%
    >12.5g/dL
  • AABB stands for
    Association for the Advancement of Blood and Biotherapies
  • Types of whole blood donation
    Allogeneic
    Autologous
  • Types of donor
    Voluntary / none numerated
    Family / replacement
    Paid / professional / commercial
  • Type of donor:
    • no any form of payments
    • low incidence and prevalence of transfusion transmissible infections
    • absence of the risk of anemia
    • donors are more willing to donate more regularly
    • expressed a commitment to donate blood during emergency
    Voluntary / none numerated
  • type of donor:
    • require to give blood when a member of patient's family or community needs it
    family / replacement
  • Type of donor:
    • Gives blood but receives money in return
    • Disadvantage: high incidence and prevalence of transfusion transmissible infection; often donors are malnourished and of poor health
    Paid / professional / commercial
  • Standard procedure and guidelines in donor screening
    Registration
    Medical history questionnaire
    Physical examination
    Blood Collection
    Post donation instruction
  • Prospective donor is unable to donate blood for a limited period of time
    Temporary deferral
  • Prospective donor is unable to donate blood for someone else for an unspecified period of time due to current regulatory requirements. This donor would not be able to donate blood until the current requirement change, these donors may be eligible to donate autologous blood
    Indefinite deferral
  • Prospective donor will never be eligible to donate blood for someone else. These donors may be eligible to donate autologous blood; some _ deferrals may result from the testing performed on a previous donation
    Permanent deferral
  • The test between a prospective recipient of a blood transfusion and his proposed donor (or donors) is known as the
    compatibility test
  • agglutination means presence of abnormal antibodies in the blood
    Antibody screen
  • determines transfusion incompatibility
    Direct antihuman globulin test
  • shows the blood group and type
    type and rh
  • shows the blood group and screens for antibodies in the recipient's blood
    type and crossmatch